| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $41.52B | +9.6% |
| Cost of Revenue | $9.27B | +7.3% |
| Gross Profit | $32.26B | +10.3% |
| R&D Expense | $5.99B | +9.1% |
| SG&A Expense | $3.00B | +5.8% |
| Operating Income | $8.33B | +15.6% |
| Interest Expense | $324.0M | +19.1% |
| Pre-tax Income | $9.52B | +28.0% |
| Income Tax | $2.06B |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.33B | -17.2% |
| Accounts Receivable | $14.34B | +20.0% |
| Current Assets | $28.22B | -5.1% |
| Total Assets | $112.31B | +9.1% |
| Current Liabilities | $37.12B | +32.7% |
| Long-term Debt | $14.44B | +71.2% |
| Total Liabilities | $53.16B | +27.3% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $15.00B | +14.5% |
| Capital Expenditures | $594.0M | -9.7% |
| Investing Cash Flow | -$8.59B | -171.6% |
| Financing Cash Flow | -$8.08B | +14.3% |
| Free Cash Flow | $14.40B | +15.8% |
| +66.2% |
| Net Income | $7.46B | +20.3% |
| EPS (Basic) | $7.85 | +21.9% |
| EPS (Diluted) | $7.80 | +22.6% |
| Stockholders' Equity |
| $59.14B |
| -3.3% |